The predictability of factor V Leiden (FV:Q(506)) gene mutation via clotting-based diagnosis of activated protein C resistance
- PMID: 15247984
- DOI: 10.1177/107602960401000309
The predictability of factor V Leiden (FV:Q(506)) gene mutation via clotting-based diagnosis of activated protein C resistance
Abstract
After the discovery of activated protein C resistance (APCR) due to factor V Leiden mutation and the causal relationship of the phenomenon with clinical thromboembolism, a wide variety of functional clotting-based assays were developed for testing of APCR in relation to the specific DNA-based analysis of FV:Q(506) Leiden. The aim of this study is to assess a clotting-based APCR assay using procoagulant crotalidae snake venom with respect to the sensitivity, specificity, and predictability for the presence of the factor V Leiden mutation. APCR testing and factor V DNA analyses have been performed concurrently on 319 patient specimens. APCR values of the patients with homozygous factor V Leiden mutation (70.4+/-13.5 s) were significantly lower (p<0.001) in comparison to the subjects with the heterozygous mutation (87.6+/-13.4 s). The assay is highly sensitive (98.7%) and specific (91.9%) for the screening of factor V Leiden mutation. The sensitivity and specificity of the APCR testing reached to 100% below the cut-off value of 120 s among the patients with homozygous factor V Leiden mutation. Therefore, this method could help the desired effective optimal screening strategy for the laboratory search of hereditary thrombophilia focusing on the diagnosis of APCR due to FV:Q(506).
Similar articles
-
Comparative analysis of "APTT vs RVVT" based activated protein C resistance assay in the diagnosis of Factor V Leiden mutation.Indian J Pathol Microbiol. 2020 Apr-Jun;63(2):247-250. doi: 10.4103/IJPM.IJPM_899_19. Indian J Pathol Microbiol. 2020. PMID: 32317524
-
[National evaluation of the diagnosis of activated protein C resistance].Rev Invest Clin. 2003 May-Jun;55(3):358-69. Rev Invest Clin. 2003. PMID: 14515684 Review. Spanish.
-
Modification of the ProC Global assay using dilution of patient plasma in factor V-depleted plasma as a screening assay for factor V Leiden mutation.Blood Coagul Fibrinolysis. 2001 Oct;12(7):569-76. doi: 10.1097/00001721-200110000-00010. Blood Coagul Fibrinolysis. 2001. PMID: 11685046
-
Resistance to activated protein C caused by factor V Leiden mutation and orthotopic liver transplantation.Transplantation. 2005 May 27;79(10):1422-7. doi: 10.1097/01.tp.0000158021.66004.19. Transplantation. 2005. PMID: 15912114
-
Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance.Semin Thromb Hemost. 2022 Sep;48(6):680-689. doi: 10.1055/s-0042-1758162. Epub 2022 Oct 12. Semin Thromb Hemost. 2022. PMID: 36223771 Review.
Cited by
-
Toxinology provides multidirectional and multidimensional opportunities: A personal perspective.Toxicon X. 2020 May 11;6:100039. doi: 10.1016/j.toxcx.2020.100039. eCollection 2020 Jun. Toxicon X. 2020. PMID: 32550594 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources